Andes Biotechnologies Company
Andes Biotechnologies is a leading nucleic acid-based drug discovery and development company focused on solid tumor cancers. The Company has discovered two novel families of long non-coding RNAs: sense (S-RNA) and antisense (AS-RNA). Both are present in all human cells, are synthesized in the mitochondria and migrate to the nucleus.
Technology:
Apps & Platforms
Industry:
Genomic and Epigenominc Instabillity
Headquarters:
Chile
Founded Date:
2008
Estimated Revenue:
$1M to $10M
Register and Claim Ownership